L-alpha-PC:Chol:DOPE-N-DBCO(69:30:1molar ratio)-Neutral Fluoroliposome Dansyl lipid (headgroup)-DBCO

   L-alpha-PC:Chol:DOPE-N-DBCO(69:30:1molar ratio)-Neutral Fluoroliposome Dansyl lipid (headgroup)-DBCO can be designed for vaccine delivery, wherein they can encapsulate antigens and adjuvants, potentially enhancing the immunogenic response.
   L-alpha-PC:Chol:DOPE-N-DBCO(69:30:1molar ratio)-Neutral Fluoroliposome Dansyl lipid (headgroup)-DBCO serves as a platform for studying pharmacokinetics, therapeutic efficacy, and the safety of liposomal systems in clinical applications.
  These liposomes can encapsulate various therapeutic agents (chemotherapeutics, peptides, nucleic acids) and facilitate their delivery to target sites, improving efficacy and reducing side effects.Utilizing the fluorescent properties of the dansyl group, researchers can visualize and track liposomes in living organisms, assessing their biodistribution and cellular uptake mechanisms.The presence of DBCO allows for the conjugation of azide-functionalized compounds, such as targeting ligands or therapeutic agents. This feature is particularly useful in creating custom-targeted liposomes for specific applications.Dansyl lipids can be used to study lipid interactions and dynamics in membranes, providing insights into membrane fluidity, phase behavior, and interactions with proteins or drugs.

msds of l-alpha-pc-chol-dope-n-dbco-69-30-1molar-ratio-neutral-fluoroliposome-dansyl-lipid-headgroup-dbco